Novel regulatory roles of omega-3 fatty acids in metabolic pathways: A proteomics approach

Nutrition and Metabolism

Volumn 11, Issue 1, 2014, Pages

  Ahmed, Abeer A ^a   Balogun, Kayode A ^a   Bykova, Natalia V ^a,b   Cheema, Sukhinder K ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE KINASE; ALDEHYDE DEHYDROGENASE; APOLIPOPROTEIN A1; FRUCTOSE BISPHOSPHATASE; KETOHEXOKINASE; MALATE DEHYDROGENASE; OMEGA 3 FATTY ACID; ORNITHINE OXOACID AMINOTRANSFERASE; PROTEIN DISULFIDE ISOMERASE; REGUCALCIN; S ADENOSYLMETHIONINE; SUCCINYL COENZYME A SYNTHETASE; SYNTHETASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CARBON METABOLISM; CITRIC ACID CYCLE; CONTROLLED STUDY; ENZYME ACTIVITY; FAT INTAKE; FEMALE; LIPID DIET; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; LOW FAT DIET; MALE; METABOLIC DISORDER; METABOLIC REGULATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

MUS;

EID: 84892461819     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-11-6     Document Type: Article

References (95)

1. Nutrigenomics and nutrigenetics: the emerging faces of nutrition. Mutch DM, Wahli W, Williamson G, FASEB J 2005 19 1602 1616 10.1096/fj.05-3911rev 16195369 (Pubitemid 41429518)
2. A low dietary ratio of omega-6 to omega-3 Fatty acids may delay progression of prostate cancer. Apte SA, Cavazos DA, Whelan KA, Degraffenried LA, Nutr Cancer 2013 65 556 562 10.1080/01635581.2013.775316 23659447
3. Genome-wide screen for modulation of hepatic apolipoprotein A-I (ApoA-I) secretion. Miles RR, Perry W, Haas JV, Mosior MK, N'Cho M, Wang JW, Yu P, Calley J, Yue Y, Carter Q, et al. J Biol Chem 2013 288 6386 6396 10.1074/jbc.M112. 410092 23322769
4. The relationship between dietary fatty acids and inflammatory genes on the obese phenotype and serum lipids. Joffe YT, Collins M, Goedecke JH, Nutrients 2013 5 1672 1705 10.3390/nu5051672 23698162
5. A critique of paradoxes in current advice on dietary lipids. Lands B, Prog Lipid Res 2008 47 77 106 10.1016/j.plipres.2007.12.001 18177743
6. Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Alvheim AR, Malde MK, Osei-Hyiaman D, Lin YH, Pawlosky RJ, Madsen L, Kristiansen K, Froyland L, Hibbeln JR, Obesity 2012 20 1984 1994 10.1038/oby.2012.38 22334255
7. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran-Salvador E, Titos E, Martinez-Clemente M, Lopez-Parra M, Arroyo V, Claria J, FASEB J 2009 23 1946 1957 10.1096/fj.08-125674 19211925
8. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL, J Exp Med 2002 196 1025 1037 10.1084/jem.20020760 12391014 (Pubitemid 35231761)
9. Why do omega-3 fatty acids lower serum triglycerides? Harris WS, Bulchandani D, Curr Opin Lipidol 2006 17 387 393 10.1097/01.mol.0000236363. 63840.16 16832161 (Pubitemid 44079475)
10. Antiarrhythmic effects of omega-3 fatty acids. Reiffel JA, McDonald A, Am J Cardiol 2006 98 50i 60i 10.1016/j.amjcard.2005.12.027 16919517 (Pubitemid 44223364)
11. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Maroon JC, Bost JW, Surg Neurol 2006 65 326 331 10.1016/j.surneu.2005.10.023 16531187 (Pubitemid 43384072)
12. Clinical trial evidence for the cardioprotective effects of omega-3 fatty acids. Harris WS, Isley WL, Curr Atheroscler Rep 2001 3 174 179 10.1007/s11883-001-0055-2 11177663
13. Omega-3 fatty acids and heart failure. Marchioli R, Silletta MG, Levantesi G, Pioggiarella R, Curr Atheroscler Rep 2009 11 440 447 10.1007/s11883-009-0066-y 19852885
14. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. Lavie CJ, Milani RV, Mehra MR, Ventura HO, J Am Coll Cardiol 2009 54 585 594 10.1016/j.jacc.2009.02.084 19660687
15. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Kris-Etherton PM, Harris WS, Appel LJ, Nutrition C, Arterioscler Thromb Vasc Biol 2003 23 20 e30 10.1161/01.ATV.0000038493.65177.94 12588785
16. n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Kuda O, Jelenik T, Jilkova Z, Flachs P, Rossmeisl M, Hensler M, Kazdova L, Ogston N, Baranowski M, Gorski J, et al. Diabetologia 2009 52 941 951 10.1007/s00125-009-1305-z 19277604
17. Omega3-Polyunsaturated fatty acids prevent lipoperoxidation, modulate antioxidant enzymes, and reduce lipid content but do not alter glycogen metabolism in the livers of diabetic rats fed on a high fat thermolyzed diet. de Assis AM, Rech A, Longoni A, Rotta LN, Denardin CC, Pasquali MA, Souza DO, Perry ML, Moreira JC, Mol Cell Biochem 2012 361 151 160 10.1007/s11010-011-1099- 4 21989716
18. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Simopoulos AP, Exp Biol Med (Maywood) 2008 233 674 688 10.3181/0711-MR-311 18408140
19. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Calder PC, Lipids 2003 38 343 352 10.1007/s11745-003-1068-y 12848278 (Pubitemid 36724290)
20. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Massaro M, Scoditti E, Carluccio MA, De Caterina R, Prostaglandins Leukot Essent Fatty Acids 2008 79 109 115 10.1016/j.plefa.2008.09.009 18951002
21. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. Adkins Y, Kelley DS, J Nutr Biochem 2010 21 781 792 10.1016/j.jnutbio.2009.12.004 20382009
22. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, Yuan C, Warnock M, Schmaier AH, Yokoyama C, et al. J Biol Chem 2007 282 22254 22266 10.1074/jbc.M703169200 17519235 (Pubitemid 47267340)
23. Nutritional proteomics: methods and concepts for research in nutritional science. Schweigert FJ, Ann Nutr Metab 2007 51 99 107 10.1159/000102101 17476098 (Pubitemid 46975986)
24. Exploration of PPAR functions by microarray technology-a paradigm for nutrigenomics. Bunger M, Hooiveld GJ, Kersten S, Muller M, Biochim Biophys Acta 2007 1771 1046 1064 10.1016/j.bbalip.2007.05.004 17632033 (Pubitemid 47198550)
25. Dietary omega-3 polyunsaturated Fatty acids alter the Fatty Acid composition of hepatic and plasma bioactive lipids in C57BL/6 mice: a lipidomic approach. Balogun KA, Albert CJ, Ford DA, Brown RJ, Cheema SK, PLoS One 2013 8 82399 10.1371/journal.pone.0082399 24278481
26. Maternal diet rich in saturated fats has deleterious effects on plasma lipids of mice. Chechi K, Cheema SK, Exp Clin Cardiol 2006 11 129 135 18651049 (Pubitemid 44018293)
27. The properties, developmental formation, and estrogen induction of ornithine aminotransferase in rat tissues. Herzfeld A, Knox WE, J Biol Chem 1968 243 3327 3332 4298129
28. Determination of serum proteins by means of the biuret reaction. Gornall AG, Bardawill CJ, David MM, J Biol Chem 1949 177 751 766 18110453
29. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Bradford MM, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
30. Isoelectric focusing management: an investigation for salt interference and an algorithm for optimization. Wu HC, Chen TN, Kao SH, Shui HA, Chen WJ, Lin HJ, Chen HM, J Proteome Res 2010 9 5542 5556 10.1021/pr1008256 20883018
31. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Laemmli UK, Nature 1970 227 680 685 10.1038/227680a0 5432063
32. Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer. Fan Y, Murphy TB, Byrne JC, Brennan L, Fitzpatrick JM, Watson RW, J Proteome Res 2011 10 1361 1373 10.1021/pr1011069 21166384
33. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M, Nat Protoc 2006 1 2856 2860 17406544
34. Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Shevchenko A, Jensen ON, Podtelejnikov AV, Sagliocco F, Wilm M, Vorm O, Mortensen P, Shevchenko A, Boucherie H, Mann M, Proc Natl Acad Sci U S A 1996 93 14440 14445 10.1073/pnas.93.25.14440 8962070 (Pubitemid 26418985)
35. Dried-droplet probe preparation on AnchorChip targets for navigating the acquisition of matrix-assisted laser desorption/ionization time-of-flight spectra by fluorescence of matrix/analyte crystals. Thomas H, Havlis J, Peychl J, Shevchenko A, Rapid Commun Mass Spectrom: RCM 2004 18 923 930 10.1002/rcm.1427 (Pubitemid 38619540)
36. Interferences and contaminants encountered in modern mass spectrometry. Keller BO, Sui J, Young AB, Whittal RM, Anal Chim Acta 2008 627 71 81 10.1016/j.aca.2008.04.043 18790129
37. Probability-based protein identification by searching sequence databases using mass spectrometry data. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS, Electrophor 1999 20 3551 3567 10.1002/(SICI)1522-2683(19991201)20:18<3551:: AID-ELPS3551>3.0.CO;2-2 (Pubitemid 30007252)
38. The role of regucalcin in nuclear regulation of regenerating liver. Yamaguchi M, Biochem Biophys Res Commun 2000 276 1 6 10.1006/bbrc.2000.3359 11006072
39. Role of regucalcin in maintaining cell homeostasis and function (review). Yamaguchi M, Int J Mol Med 2005 15 371 389 15702226
40. Role of endogenous regucalcin in transgenic rats: suppression of kidney cortex cytosolic protein phosphatase activity and enhancement of heart muscle microsomal Ca2 + -ATPase activity. Yamaguchi M, Morooka Y, Misawa H, Tsurusaki Y, Nakajima R, J Cell Biochem 2002 86 520 529 10.1002/jcb.10249 12210758 (Pubitemid 36076169)
41. The role of intracellular Ca2+ in the regulation of gluconeogenesis. Kraus-Friedmann N, Feng L, Metab 1996 45 389 403 10.1016/S0026-0495(96)90296-6 (Pubitemid 26102647)
42. The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice. Hamada Y, Nagasaki H, Fuchigami M, Furuta S, Seino Y, Nakamura J, Oiso Y, Metab 2013 62 734 742 10.1016/j.metabol.2012.10.015
43. Exogenous regucalcin suppresses osteoblastogenesis and stimulates adipogenesis in mouse bone marrow culture. Yamaguchi M, Weitzmann MN, Baile CA, Murata T, Integr Biol (Camb) 2012 4 1215 1222 10.1039/c2ib20118f 22868942
44. Regucalcin and metabolic disorders: osteoporosis and hyperlipidemia are induced in regucalcin transgenic rats. Yamaguchi M, Mol Cell Biochem 2010 341 119 133 10.1007/s11010-010-0443-4 20349117
45. Involvement of regucalcin in lipid metabolism and diabetes. Yamaguchi M, Murata T, Metabolism 2013 62 1045 1051 10.1016/j.metabol.2013.01.023 23453039
46. Apolipoprotein A-I (Milano): current perspectives. Chiesa G, Sirtori CR, Curr Opin Lipidol 2003 14 159 163 10.1097/00041433-200304000-00007 12642784 (Pubitemid 36521186)
47. Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome. Burillo E, Mateo-Gallego R, Cenarro A, Fiddyment S, Bea AM, Jorge I, Vazquez J, Civeira F, Lipids Health Dis 2012 11 116 10.1186/1476-511X-11-116 22978374
48. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Sampath H, Ntambi JM, Annu Rev Nutr 2005 25 317 340 10.1146/annurev.nutr.25. 051804.101917 16011470 (Pubitemid 41209005)
49. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Mato JM, Alvarez L, Ortiz P, Pajares MA, Pharmacol Ther 1997 73 265 280 10.1016/S0163-7258(96)00197-0 9175157 (Pubitemid 27224439)
50. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C, Am J Clin Nutr 2001 74 723 729 11722952 (Pubitemid 33101791)
51. Plasma homocysteine level and hepatic sulfur amino acid metabolism in mice fed a high-fat diet. Yun KU, Ryu CS, Oh JM, Kim CH, Lee KS, Lee CH, Lee HS, Kim BH, Kim SK, Eur J Nutr 2013 52 127 134 10.1007/s00394-011-0294-0 22209966
52. Plasma omega-3 fatty acid levels negatively and omega-6 fatty acid levels positively associated with other cardiovascular risk factors including homocysteine in severe obese subjects. Mehmetoglu I, Yerlikaya FH, Kurban S, Polat H, Asia Pac J Clin Nutr 2012 21 519 525 23017310
53. Effect of n-3 polyunsaturated fatty acid on gene expression of the critical enzymes involved in homocysteine metabolism. Huang T, Wahlqvist ML, Li D, Nutr J 2012 11 6 10.1186/1475-2891-11-6 22260268
54. Adenosine kinase and ribokinase-the RK family of proteins. Park J, Gupta RS, Cell Mol Life Sci 2008 65 2875 2896 10.1007/s00018-008-8123-1 18560757
55. Human placental adenosine kinase: purification and characterization. Andres CM, Palella TD, Fox IH, Adv Exp Med Biol 1979 122B 41 43 232641
56. Adenosine kinase deficiency disrupts the methionine cycle and causes hypermethioninemia, encephalopathy, and abnormal liver function. Bjursell MK, Blom HJ, Cayuela JA, Engvall ML, Lesko N, Balasubramaniam S, Brandberg G, Halldin M, Falkenberg M, Jakobs C, et al. Am J Hum Genet 2011 89 507 515 10.1016/j.ajhg.2011.09.004 21963049
57. Adenosine kinase inhibition selectively promotes rodent and porcine islet beta-cell replication. Annes JP, Ryu JH, Lam K, Carolan PJ, Utz K, Hollister-Lock J, Arvanites AC, Rubin LL, Weir G, Melton DA, Proc Natl Acad Sci USA 2012 109 3915 3920 10.1073/pnas.1201149109 22345561
58. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A, Cochrane Database Syst Rev 2008 Issue 1. Art. No.:CD003205. doi:10.1002/14651858. CD003205.pub2.
59. The effects of n-3 polyunsaturated fatty acids by gavage on some metabolic enzymes of rat liver. Yilmaz HR, Songur A, Ozyurt B, Zararsiz I, Sarsilmaz M, Prostaglandins Leukot Essent Fatty Acids 2004 71 131 135 10.1016/j.plefa.2004.03.002 15207530 (Pubitemid 38881252)
60. Function, structure and evolution of fructose-1,6-bisphosphatase. Marcus F, Rittenhouse J, Gontero B, Harrsch PB, Arch Biol Med Exp (Santiago) 1987 20 371 378 8816077
61. Identification of novel protein targets regulated by maternal dietary fatty acid composition in neonatal rat liver. Novak EM, Lee EK, Innis SM, Keller BO, J Proteomics 2009 73 41 49 10.1016/j.jprot.2009.07.008 19651254
62. Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Manganelli G, Masullo U, Passarelli S, Filosa S, Cardiovasc Hematol Disord Drug Targets 2013 13 73 82 10.2174/1871529X11313010008 23534950
63. Identification of the cDNA encoding human 6-phosphogluconolactonase, the enzyme catalyzing the second step of the pentose phosphate pathway (1). Collard F, Collet JF, Gerin I, Veiga-da-Cunha M, Van Schaftingen E, FEBS Lett 1999 459 223 226 10.1016/S0014-5793(99)01247-8 10518023 (Pubitemid 29475035)
64. A quick look at biochemistry: carbohydrate metabolism. Dashty M, Clin Biochem 2013 46 1339 1352 10.1016/j.clinbiochem.2013.04.027 23680095
65. The oxidative pentose phosphate pathway: structure and organisation. Kruger NJ, von Schaewen A, Curr Opin Plant Biol 2003 6 236 246 10.1016/S1369-5266(03)00039-6 12753973 (Pubitemid 36704509)
66. Fructose, insulin resistance, and metabolic dyslipidemia. Basciano H, Federico L, Adeli K, Nutr Metab 2005 2 5 10.1186/1743-7075-2-5 (Pubitemid 40412656)
67. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sanchez-Lozada LG, Am J Clin Nutr 2007 86 899 906 17921363 (Pubitemid 47538288)
68. Dietary fructose and the metabolic syndrome. Miller A, Adeli K, Curr Opin Gastroenterol 2008 24 204 209 10.1097/MOG.0b013e3282f3f4c4 18301272 (Pubitemid 351322788)
69. Bovine liver fructokinase: purification and kinetic properties. Raushel FM, Cleland WW, Biochem 1977 16 2169 2175 10.1021/bi00629a020 (Pubitemid 8120884)
70. Beneficial effects of omega-3 fatty acids on the consequences of a fructose diet are not mediated by PPAR delta or PGC1 alpha. Karsenty J, Landrier JF, Rousseau-Ralliard D, Robbez-Masson V, Margotat A, Deprez P, Lechene P, Grynberg A, Lairon D, Planells R, Gastaldi M, Eur J Nutr 2013 52 1865 1874 10.1007/s00394-012-0488-0 23269653
71. Malate dehydrogenase: distribution, function and properties. Musrati RA, Kollarova M, Mernik N, Mikulasova D, Gen Physiol Biophys 1998 17 193 210 9834842 (Pubitemid 128522880)
72. Protective effect of omega-3 polyunsaturated fatty acids (PUFAs) on sodium nitroprusside-induced nephrotoxicity and oxidative damage in rat kidney. Khan MW, Priyamvada S, Khan SA, Khan S, Naqshbandi A, Yusufi AN, Hum Exp Toxicol 2012 31 1035 1049 10.1177/0960327112444475 22549094
73. Succinyl-CoA synthetase structure-function relationships and other considerations. Nishimura JS, Adv Enzymol Relat Areas Mol Biol 1986 58 141 172 3521216
74. Succinyl-CoA synthetase is a phosphate target for the activation of mitochondrial metabolism. Phillips D, Aponte AM, French SA, Chess DJ, Balaban RS, Biochemistry 2009 48 7140 7149 10.1021/bi900725c 19527071
75. Overexpression of ornithine aminotransferase: consequences on amino acid homeostasis. Ventura G, De Bandt JP, Segaud F, Perret C, Robic D, Levillain O, Le Plenier S, Godard C, Cynober L, Moinard C, Br J Nutr 2009 101 843 851 10.1017/S0007114508043389 18680626
76. Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats. Marsman HA, Heger M, Kloek JJ, Nienhuis SL, ten Kate FJ, van Gulik TM, Dig Liver Dis 2011 43 984 990 10.1016/j.dld.2011.07.009 21840275
77. High protein diet induces pericentral glutamate dehydrogenase and ornithine aminotransferase to provide sufficient glutamate for pericentral detoxification of ammonia in rat liver lobules. Boon L, Geerts WJ, Jonker A, Lamers WH, Van Noorden CJ, Histochem Cell Biol 1999 111 445 452 10.1007/s004180050380 10429966 (Pubitemid 29302024)
78. Catabolism of arginine and ornithine in the perfused rat liver: effect of dietary protein and of glucagon. O'Sullivan D, Brosnan JT, Brosnan ME, Am J Physiol Endocrinol Metab 2000 278 516 E521 10710507
79. Glutamine metabolism and its physiologic importance. Smith RJ, JPEN J Parenter Enteral Nutr 1990 14 40S 44S 10.1177/014860719001400402 2205730
80. Proteins of the PDI family: unpredicted non-ER locations and functions. Turano C, Coppari S, Altieri F, Ferraro A, J Cell Physiol 2002 193 154 163 10.1002/jcp.10172 12384992
81. Substrate recognition by the protein disulfide isomerases. Hatahet F, Ruddock LW, FEBS J 2007 274 5223 5234 10.1111/j.1742-4658.2007.06058.x 17892489 (Pubitemid 47512369)
82. Changes in liver proteome expression of Senegalese sole (Solea senegalensis) in response to repeated handling stress. Cordeiro OD, Silva TS, Alves RN, Costas B, Wulff T, Richard N, de Vareilles M, Conceicao LE, Rodrigues PM, Mar Biotechnol (NY) 2012 14 714 729 10.1007/s10126-012-9437-4 22327442
83. Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signalling to the Akt-mTOR-S6K1 pathway and insulin sensitivity. Gingras AA, White PJ, Chouinard PY, Julien P, Davis TA, Dombrowski L, Couture Y, Dubreuil P, Myre A, Bergeron K, et al. J Physiol 2007 579 269 284 10.1113/jphysiol.2006.121079 17158167
84. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Smith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ, Mittendorfer B, Am J Clin Nutr 2011 93 402 412 10.3945/ajcn.110.005611 21159787
85. Changes in the fatty acid composition of the liver with the administration of N-3 polyunsaturated fatty acids and the effects on warm ischemia/reperfusion injury in the rat liver. Iwasaki W, Kume M, Kudo K, Uchinami H, Kikuchi I, Nakagawa Y, Yoshioka M, Yamamoto Y, Shock 2010 33 306 314 10.1097/SHK.0b013e3181b2ffd2 19543146
86. Protection against in vivo liver ischemia-reperfusion injury by n-3 long-chain polyunsaturated fatty acids in the rat. Zuniga J, Venegas F, Villarreal M, Nunez D, Chandia M, Valenzuela R, Tapia G, Varela P, Videla LA, Fernandez V, Free Radic Res 2010 44 854 863 10.3109/10715762.2010.485995 20528561
87. Role of regucalcin in calcium signaling. Yamaguchi M, Life Sci 2000 66 1769 1780 10.1016/S0024-3205(99)00602-5 10809175 (Pubitemid 30198583)
88. Hepatic aldehyde dehydrogenases and lipid peroxidation. Hjelle JJ, Petersen DR, Pharmacol Biochem Behav 1983 18 Suppl 1 155 160 6634832
89. Aldehyde dehydrogenase-2 deficiency aggravates cardiac dysfunction elicited by endoplasmic reticulum stress induction. Liao J, Sun A, Xie Y, Isse T, Kawamoto T, Zou Y, Ge J, Mol Med 2012 18 785 793 22430940
90. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans. Nalsen C, Vessby B, Berglund L, Uusitupa M, Hermansen K, Riccardi G, Rivellese A, Storlien L, Erkkila A, Yla-Herttuala S, et al. J Nutr 2006 136 1222 1228 16614408
91. Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients. Mori TA, Dunstan DW, Burke V, Croft KD, Rivera JH, Beilin LJ, Puddey IB, Metabolism 1999 48 1402 1408 10.1016/S0026-0495(99)90150-6 10582548 (Pubitemid 29536439)
92. Platelet redox balance in diabetic patients with hypertension improved by n-3 fatty acids. McDonald DM, O'Kane F, McConville M, Devine AB, McVeigh GE, Diabetes Care 2013 36 998 1005 10.2337/dc12-0304 23238663
93. Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. Kim KM, Kim YS, Jung DH, Lee J, Kim JS, Exp Cell Res 2012 318 152 159 10.1016/j.yexcr.2011.10.013 22036650
94. Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy. Jack M, Wright D, Transl Res 2012 159 355 365 10.1016/j.trsl.2011.12.004 22500508
95. Dimerumic acid attenuates receptor for advanced glycation endproducts signal to inhibit inflammation and diabetes mediated by Nrf2 activation and promotes methylglyoxal metabolism into d-lactic acid. Lee BH, Hsu WH, Hsu YW, Pan TM, Free Radic Biol Med 2013 60 7 16 23434766